Author: Marie Jones

The Governor of Central Java, Indonesia, Ganjar Pranowo, established SMK Negeri Jawa Tengah (SMKN Jateng), a free school for underprivileged students with the concept of a boarding school. Inaugurated on June 2, 2014, the school is currently located in three places, namely Semarang City, Purbalingga Regency, and Pati Regency. The presence of SMKN Jateng aims to reduce poverty rates in Central Java through education. All education expenses are borne by the Central Java Provincial Government’s regional revenues and expensitures budget (APBD) along with other stakeholders’ financial contribution. All student needs such as boarding, food, uniforms, work clothes, stationery, and other…

Read More

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, has been honored with the Best Bioprocessing Supplier Award for Cell and Gene Therapy at the Biopharma Excellence Awards (BEA) India Edition 2023, organized by IMAPAC in Pune, India. The award recognizes Avantor’s outstanding efforts to support the expansion of life-altering innovative cell and gene therapies to treat complex disease. Avantor is focused on making valuable contributions to cell and gene therapy production and offers expertise, technology capabilities and commitment to providing solutions. Recently, Avantor was…

Read More

Blockpass is proud to announce that, through consulting and advisory firm Charmwood Risk Management, Blockpass UK is now certified to ISO 27001 by The British Assessment Bureau, a UKAS Accredited Organisation. The award of this certificate (meeting the requirements of BS EN ISO/IEC 27001:2017) confirms Blockpass’ ability to provide KYC and AML tools for cryptocurrencies, Defi and other regulated industries globally, demonstrating the suitability of Blockpass for companies seeking regulatory solutions in any jurisdiction. The certificate is available to view here: https://cvs.babcert.com/babcert.asp?c=241611&v=k34q1g2c2q Charmwood Risk Management is a consulting and advisory firm with a global team specializing in supporting businesses with; implementation,…

Read More

Achieved Breakthroughs in Product Development With Continued Efforts to Improve its Third-generation Semiconductor GaN Industry Chain HG Semiconductor Limited (HG Semiconductor, together with its subsidiaries, the Group; HKG: 6908) announced its audited consolidated results for the year ended 31 December 2022 (the Year). HG Semiconductor actively developed its new third-generation semiconductor business during the Year, by further accelerating the pace of research and development (R&D) and application of gallium nitride (GaN) technology and achieving several important milestones. During the Year, since the third-generation semiconductor business was still in investment and R&D stage, the Group’s revenue was mainly contributed from the…

Read More

TOKYO, Apr 3, 2023 – (JCN Newswire) – TANAKA Holdings Co., Ltd. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), the pure holding company of TANAKA Group, announced today that it has formulated a diversity, equity, and inclusion (DE&I) declaration. TANAKA Group considers the individuality of each employee is the origin of value creation and positions the promotion of DE&I as one of our key management strategies. We declare to make company-wide efforts to promote DE&I. To create new innovations for a better future and to achieve happiness for our employees to believe in their own potential, we will…

Read More

Indonesia’s Ministry of Communications and Informatics (MCI) is preparing digital infrastructure to support the successful ASEAN Chairmanship 2023. Acting Director-General of Posts and Informatics Operations of the Ministry of Communications and Informatics, Ismail, stated that his ministry is continuously monitoring the telecommunications network to maintain its quality. “One of MCI’s tasks is to provide telecommunications networks and internet access to ensure the smooth running of ASEAN Chairmanship 2023,” he emphasized in Jakarta on Friday, March 31, 2023. Ismail also stated that specifically for the ASEAN Summit slated to be held in May 2023 in Labuan Bajo, East Nusa Tenggara, MCI…

Read More

Legend Holdings Corporation (HKG: 3396) announced its audited annual results for the year ended December 31, 2022 (the Reporting Period) on March 31, 2023. During the Reporting Period, Legend Holdings achieved revenue of RMB483.7 billion and net profit attributable to equity holders of the Company of RMB1.167 billion. In 2022, uncertainties in the international situation continued to increase, including rising global inflation and significant volatility in international financial markets and commodity markets, which also had a significant impact on the Company’s performance. The industrial incubations and investments segment successfully promoted the listing of over 60 enterprises in the last three…

Read More

UK’s Companies House lacks safeguards to identify investment scams To prove how easy it is for anyone to launch a scam site, the Global Anti Scam Alliance and ScamAdviser launched ‘ScamAdviser Coin’ in the lead-up to April Fool’s Day 2023. The goal of this campaign was to highlight the importance of forming better policies to combat scammers. Last year, nearly 300 million consumers lost more than $55 billion, according to the Global State of Scams 2022 report. Especially, investment scams continued to rise, caused by digitalization, high inflation, and the increasing cost of living. Within a matter of days, a…

Read More

Revenue Up by 7.1% to RMB28.78 Billion Adjusted non-HKFRS Profit Attributable to the Owners of the Parent Up by 16.4% to RMB2.99 Billion Sales of Innovative Products Accounts for 23.5% of Revenue Sino Biopharmaceutical Limited (Sino Biopharm or the Company, together with its subsidiaries, the Group) (HKG:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2022. Development Highlights Oncology Innovative Drugs Focus V (Anlotinib Hydrochloride Capsules) has been approved for five indications: third-line non-small cell lung cancer, third-line small cell lung cancer, soft tissue sarcoma, medullary thyroid cancer…

Read More

HTSC (HKG: 6886; the Company), a leading global financial services provider, is pleased to announce the Company’s annual results for the year ended December 31, 2022. Revenue for the year was RMB 46.82 billion Profit attributable to shareholders amounted to RMB 11.05 billion Total equity attributable to shareholders of the Company grew 11.23% year-on-year to RMB 165.09 billion. The Company proposed a final dividend of RMB 0.45 per share The wealth management business reported a revenue of RMB 23.48 billion and continued to account for the majority of the Company’s total revenue of 50.15%. Revenues from the institutional services business…

Read More

As the global new energy automobile industry continues to experience rapid growth, there has been an acceleration in the R&D and application of new products and technologies. Technological innovation is driving the continuous upgrading of the industry. At the same time, the automotive industry is also ushering in a new round of disruptive changes amidst the wave of digitalization and intelligence. Amidst changes in its internal and external environments, Wuling Motors Holdings Limited (the “Company” or “Wuling Motors”,Stock Code:00305.HK) has shown remarkable innovation in leading the way toward high-quality development. Today, the Company delivered impressive results for 2022, with annual…

Read More

ACROMETA Group Limited, an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biotechnology, pharmaceutical, research and academia sectors, has entered into a Sales and Purchase Agreement (“the Agreement”) for an additional 40% of the outstanding shares of Life Sciences Incubator Pte Ltd (“LSI”) for a total consideration of S$1.6 million payable in tranches, based on the realisation of agreed milestones in its immediate expansion plan. Upon completion of the purchase, the Group will control 70% of LSI, up from the current 30%. The Agreement updates and follows from the Letter of Intent (“LOI”)…

Read More

Earable® Neuroscience U.S. (“Earable®”), is pleased to announce a strategic partnership with Singapore-based Excelpoint Technology Pte. Ltd., (“Excelpoint”) to accelerate the commercialisation of the world’s first AI-powered consumer wearable, FRENZ™ Brainband, which tracks and stimulates brain activities to enhance mental well-being through improvements in sleep, relaxation and focus. FRENZ™ Brainband can precisely tracks vital data points in real-time, provides instant personalized feedback with cognitive behavioral therapy content via the integrated bone-conduction speakers, and leverages AI and machine learning algorithms to continuously evolve and provide meaningful insights to enhance mental well-being for individuals. Since the COVID-19 pandemic began, researchers around the…

Read More

Embarking on a New Journey of High-Quality Development GF Securities Co., Ltd. (GF Securities or the Company, together with its subsidiaries, the Group; HKG: 1776; SZSE: 000776), one of the most influential securities companies in the Chinese capital market, announced its annual results for the twelve months ended 31 December 2022 (the “Reporting Period”). In the face of the complicated internal and external situation, embracing the working philosophy of “making positive changes and promoting the high-quality development of the Company to a new level” and “firmly focus on principal duties and businesses and improve core business”, GF Securities continued to…

Read More

PT Wintermar Offshore Marine Tbk (WINS:JK) recorded FY2022 gross profit of US$11.2 million, an 88% YOY growth, on the back of rising utilization and charter rates, and a 510%YOY jump in net profit to US$1.1 million. Higher utilization and rising charter rates contributed to a strong operational performance in FY2022 with EBITDA up 28% to US$17.5 million on total revenue of US$61 million (+44%YOY). Owned Vessel Division Offshore upstream activity picked up steadily over the course of FY2022 amidst a sustained rise in oil prices and continued tensions in Ukraine. Demand for OSVs, in particular in the higher value vessels,…

Read More

Nationwide Presence, Global Expansion Self-built and Operation Management Approach Drives Market Shares China Risun Group Limited (China Risun, or the Group, HKG: 1907), a leading global integrated coke, coking chemicals and refined chemicals producer and supplier and relevant operation management services provider in China, announced today its annual results for the year ended 31 December 2022 (the reporting year). The Group continued its expansion in the annual capacity of all the products and its further refining ability to high-end chemicals products. It has also strategically focused on increasing its market share through nationwide distribution and global expansion initiatives. Revenue for…

Read More

Benefiting from Effective Management of Supply Chain and Project Execution in the Business Segment of Liquid and Bioprocess System, the Group Recorded a Growth of Over 10%; To Seize the Rapid Development Opportunities of Cell and Gene Therapy Sector and to Enlarge Business Potential in the Future Austar Lifesciences Limited (AUSTAR or Company) (HKG: 6118), a technology-based pharmaceutical engineering solution provider, together with its subsidiaries (collectively the Group or AUSTAR Group), announced its audited annual results for the year ended 31 December 2022 (Reporting Period). Although the Group was affected by the requirements for epidemic control causing challenges to its…

Read More

On 28th March 2023, Rxilient Biotech (a portfolio company of Legend Capital) and Junshi Biosciences made a joint announcement that two parties will form a joint venture to develop and commercialize toripalimab in Thailand, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, and Vietnam[1]. Toripalimab is an anti-PD-1 monoclonal antibody independently developed by Junshi Biosciences. Junshi Biosciences has conducted over 30 clinical trials globally (in China, the USA, Southeast Asia, and Europe) covering more than 15 indications, including cancers of the lung, nasopharynx, esophagus, stomach, bladder, breast, liver, kidney, and skin. Six of these indications have been approved in China,…

Read More

– Associate Professor Masashi Kaneko of Osaka University presented Gold Award for modeling of precious metal extraction and separation using Moessbauer spectroscopy parameters and computational chemistry. Also receiving a Gold Award is Professor Seiji Miura of Hokkaido University for experiments to achieve microstructure control of precious metal-based high-entropy alloys. – Development of precious metal extraction and separation technologies using computational chemistry and development of microstructure-controlled precious metal-based high-entropy alloys received awards. TOKYO, Mar 31, 2023 – (JCN Newswire) – The TANAKA Memorial Foundation’s Representative Director, Hideya Okamoto, announced the recipients of the FY2022 Precious Metals Research Grants. Following a rigorous screening process, the Gold…

Read More

Eminent recommendations have praised Ephraim’s initial fundraising book for its effectiveness in sending underprivileged children in Africa to school Queen Jennifer Ephraim, a renowned beauty queen, humanitarian, and fundraising expert, recently launched a highly anticipated book titled “DILEMMA OF THE NIGERIAN GIRL CHILD” on Amazon.com through the Jennifer Ephraim Foundation. The book is aimed at providing innovative solutions to issues faced by the girl child in Africa, such as early marriages, child abuse, and sex trafficking. Unlike traditional fundraising methods like cookie sales and car washes, the book suggests ideas to direct money into classrooms, schools, and districts continuously. It…

Read More